Michael James Newman insider trades
Open-market stock purchases and sales by Michael James Newman, CSO and Director at Indaptus Therapeutics, Inc, from SEC Form 4 filings since Aug 4, 2021.
Recent trades
| Date | Stock | Trade | Value |
|---|---|---|---|
| Dec 22, 2025 | INDP Indaptus Therapeutics, Inc | Bought (not open market) | $106K |
Companies traded
- INDP Indaptus Therapeutics, Inc: 2 sales, last Dec 22, 2025
Get free alerts when Michael James Newman files a new trade →